169(top 1%)
papers
1.5K(top 2%)
citations
19(top 2%)
h-index
32(top 2%)
g-index
187
all documents
1.7K
doc citations
684
citing journals

Top Articles

#TitleJournalYearCitations
1Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trialLancet Oncology, The2018107
2Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysisEuropean Journal of Cancer201493
3Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung CancerAnnals of Thoracic Surgery201587
4Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trialLancet Respiratory Medicine,the202262
5Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLCJournal of Thoracic Oncology202157
6Magnifying endoscope with NBI to predict the depth of invasion in laryngo‐pharyngeal cancerLaryngoscope201542
7A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208)Annals of Surgery201941
8Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)European Journal of Cancer201640
9International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO‐GC‐1)Annals of Gastroenterological Surgery202239
10Breathing–swallowing discoordination is associated with frequent exacerbations of COPDBMJ Open Respiratory Research201738
11Final overall survival results of WJTOG 3405, a randomized phase 3 trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR).Journal of Clinical Oncology201436
12Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort studyArthritis Research and Therapy201833
13Flexible next‐generation robotic surgical system for transoral endoscopic hypopharyngectomy: A comparative preclinical studyHead and Neck201832
14Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patientsBMJ Open201932
15A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure ManagementAnnals of the American Thoracic Society202031
16Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapyInternational Journal of Clinical Oncology201628
17Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodiesRheumatology201727
18Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsetsLupus201426
19Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancerBreast Cancer201721
20Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicatedAmerican Journal of Transplantation201921
21Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional studyScandinavian Journal of Rheumatology201920
22Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases—a Japanese Nationwide SurveyJournal of Gastrointestinal Surgery202019
23Reminiscence therapy using virtual reality technology affects cognitive function and subjective well-being in older adults with dementiaCogent Psychology202118
24A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study 4407G (WJOG4407G).Journal of Clinical Oncology201418
25S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT studyESMO Open201717
26Comprehensive data of 3,820 patients newly diagnosed with colorectal liver metastasis between 2005 and 2007: report of a nationwide survey in JapanJournal of Hepato-Biliary-Pancreatic Sciences201817
27The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)Journal of Cancer201817
28Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patientsBreast Cancer201917
29A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignanciesInvestigational New Drugs202016
30Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failureHeart202116
31Durable tumor remission in patients with platinum-resistant ovarian cancer receiving nivolumab.Journal of Clinical Oncology201516
32Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR MutationsJTO Clinical and Research Reports202115
33Anti–USAG-1 therapy for tooth regeneration through enhanced BMP signalingScience Advances202115
34Phenotyping of IgG4-related diseases based on affected organ pattern: A multicenter cohort study using cluster analysisModern Rheumatology202114
35Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT)Oncologist202114
36Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar MacrophagesCirculation202214
37The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patientsNpj Precision Oncology201713
38Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoringClinical Trials201913
39Bone mineral density correlates with survival after resection of extrahepatic biliary malignanciesClinical Nutrition201913
40Long‐term outcome of liver resection for colorectal metastases in the presence of extrahepatic disease: A multi‐institutional Japanese studyJournal of Hepato-Biliary-Pancreatic Sciences202013
41Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumabChinese Journal of Cancer201612
42A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trialCancer Medicine201812
43Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional studyRheumatology International201812
44Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancerScientific Reports202112
45A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trialGastric Cancer201811
46A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)European Journal of Cancer201811
47Third Dentition Is the Main Cause of Premolar Supernumerary Tooth FormationJournal of Dental Research201911
48Assessment of autonomic nervous system function in nursing students using an autonomic reflex orthostatic test by heart rate spectral analysisBiomedical Reports201510
49A High Portal Venous Pressure Gradient Increases Gut-Related Bacteremia and Consequent Early Mortality After Living Donor Liver TransplantationTransplantation201810
50Long-term preservation of planar cell polarity in reversed tracheal epitheliumRespiratory Research201810